E
Elixia | Clinical Renal Associates
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Empagliflozin
BI 690517
Zetomipzomib
MZE829
KZR-616
Parent organization
This site is a part of Elixia
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 4 total trials
This is purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease
Enrolling
Proteinuric Kidney Disease
Drug: MZE829
This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study....
Enrolling
Kidney Disease, Chronic
Drug: Placebo matching BI 690517
Drug: Empagliflozin
Trial sponsors
K
M
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems